Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR mHealth and uHealth

Date Submitted: Dec 17, 2020
Date Accepted: Dec 17, 2020

The final, peer-reviewed published version of this preprint can be found here:

Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study

Hua X, Li C, Pogue JM, Sharma VS, Karaiskos I, Kaye KS, Tsuji BT, Bergen PJ, Zhu Y, Song J, Li J

Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study

JMIR Mhealth Uhealth 2020;8(12):e26593

DOI: 10.2196/26593

PMID: 33338026

PMCID: 7775816

Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study

  • Xueliang Hua; 
  • Chen Li; 
  • Jason M Pogue; 
  • Varun S Sharma; 
  • Ilias Karaiskos; 
  • Keith S Kaye; 
  • Brian T Tsuji; 
  • Phillip J Bergen; 
  • Yan Zhu; 
  • Jiangning Song; 
  • Jian Li

ABSTRACT

REMOVE


 Citation

Please cite as:

Hua X, Li C, Pogue JM, Sharma VS, Karaiskos I, Kaye KS, Tsuji BT, Bergen PJ, Zhu Y, Song J, Li J

Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development Study

JMIR Mhealth Uhealth 2020;8(12):e26593

DOI: 10.2196/26593

PMID: 33338026

PMCID: 7775816

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.